In truth, they regularly do. Just take a look underneath at the 444 S&P 500 components that had been part of the index at some point of the 2007-09 selloff. Only a handful fell even close to the undergo-market minimum.

Meanwhile, nearly 1 / 4 hemorrhaged 70% in their value or more!

Regular readers recognize that I’m looking forward to an alleviation rally any hour now. That can be a terrific opportunity to do not forget selling those four dividend shares, which might be going to face giant headwinds in 2019 – particularly if the wider markets struggle.

Johnson & Johnson

Dividend Yield: 2.Eight%

Typically, consumer staples businesses – which supply the sorts of goods that human beings certainly need irrespective of what economic scenario arises – aren’t any-brainer investments in a down market. If you manifest to feature a massive healthcare enterprise to the combination, all of the higher. And but, Johnson & Johnson – that is chargeable for Johnson’s, Band-Aid, Neutrogena, and different client brands, in addition to drugs such as Remicade and Stelara – couldn’t be more unbuyable proper now.

J&J spent 2018 in the courtroom fighting off cases related to claims that their child powder contained asbestos and precipitated mesothelioma to a few individuals who were uncovered to it. “We will maintain to shield the protection of our product because it does no longer include asbestos or reason mesothelioma,” the business enterprise stated in May after dropping a ruling in California.

But Reuters dropped a bombshell file in December saying that internal files “display that the company’s powder changed into from time to time tainted with carcinogenic asbestos and that J&J saved that statistics from regulators and the general public” for decades. JNJ tanked 13% in 5 trading days following Reuters’ file, and that very possibly received’t be the closing of it. Johnson & Johnson now not most effective risks suffering a huge reputational hit to its customer manufacturers, however its prison course forward abruptly seems fraught with potholes.

In some conditions like this, shares can be overwhelmed to the factor of deep fee and excessive yields, but that’s now not the case right here. JNJ trades at 15 instances forward income estimates, that’s simply on par with the marketplace, and it nonetheless yields less than the ten-year right now. That’s no price, especially for a business enterprise that just began a clean new leg of uncertainty and nightmarish PR.

Wells Fargo

Dividend Yield: three.7%

Speaking of PR nightmares, permit’s talk about Wells Fargo.

Wells Fargo simply has more than one advantages over JNJ right off the bat. It yields barely higher at the north of 3%, it’s really a good deal greater value-priced at just 9 instances estimates, and it’s a great deal farther along the scandal lifecycle than Johnson & Johnson. Its fake-bills scandal, wherein tens of millions of unauthorized money owed have been created on behalf of unknowing clients, commenced rolling downhill Sept. Eight, 2016, so we’re extra than two years in.

Well, this is, we’re extra than two years in on that scandal.

Along the way, Wells Fargo continues on stepping on self-laid landmines, such as masses of unintentional foreclosures from a computer glitch, charging erroneous mortgage charges, nudging people into coverage and different merchandise they didn’t really want, as well as several different scandals.

Wells Fargo, as soon as viewed as the Gallant of Wall Street’s “Big Four” banks, has speedy converted into Goofus. The stock has genuinely stalled out and has traded flat for more or less four years now. Worse nevertheless, the Federal Reserve put certain increase restrictions at the bank that WFC assume will last for the primary 1/2 of 2019, but ought to stretch even longer.

A less-than-enthusiastic economic outlook for 2019 and probably a slowdown in hobby-fee hikes will make subsequent year hard for financials in well-known. And Wells Fargo is the worst alternative in that discipline.

B&G Foods

Dividend Yield: 6.5%

B&G Foods looks as if your ordinary defensive customer staple. It offers an extra-than-adequate yield – in truth, at greater than 6%, it’s suspiciously strong. And at the same time as you could no longer be acquainted with the name B&G Foods, you’re nearly truly familiar with its brands: Green Giant greens, Ortega Mexican foods, Mrs. Dash seasonings, Spice Islands spices, and SnackWell’s cookies.

This is the form of inventory that needs to maintain up nicely incorrect instances and bad, and actually, it has tended to do all proper during marketplace downturns. BGS is without a doubt almost breakeven over the last month, versus a nearly 15% fall for the S&P 500. Better still, the company has grown at an awesome charge during the last few years, more or less doubling revenues between 2014 ($848 million) and 2017 ($1.7 billion)

Under ordinary circumstances, this would seem like an excellent under-the-radar play in 2019. But I think BGS is due for a slowdown in 2019, for a few motives.

For one, plenty of its growth of the past few years has come through a competitive acquisition approach – it sold Green Giant from General Mills in 2015, for instance, and Static Guard and Kleen Guard from Unilever in 2011. However, the employer has racked up an outstanding pile of $2.2 billion in long-term debt towards pretty much $206 million in coins. The organization is levered heavily, too, projecting for the duration of its Q2 name that it might cease the 12 months with net debt at 5.5x to five.6x seasoned forma adjusted EBITDA.

Moreover, that incredible dividend is pretty the economic weight, with its ahead annual fee of $1.90 coming in at 95% of this 12 months’ projected earnings. Those earnings, through the manner, are a step down from 2017’s $2.12 in keeping with share, and 2019 is anticipated to nevertheless be well underneath that quantity, at $2.03 in line with the percentage. That projected discern accompanies Wall Street estimates for a three.3% the pullback on the top line.

B&G isn’t always a ticking time bomb, however, it may be a quagmire for new cash in 2019. This is a stock to revisit and re-evaluate at a later time.

Las Vegas Sands

Dividend Yield: five.6%

Almost a yr in the past to the date, I said that online casino operator Las Vegas Sands “will have something to prove to income traders in overdue January, while the enterprise needs to announce a development to its quarterly payout.”

It proved something, all right.

LVS passed out a mere two-cent (2.7%) dividend boost to seventy-five cents consistent with the share in early 2018 – a 12 months after it produced a penny-per-proportion hike for its shareholders. It’s a mirrored image no longer just of slowing earnings, but also a more and more cramped payout ratio that sits around 87% for its trailing 12-month income.

I don’t count on lots better for 2019.

Q4 2018’s surprising stock-market losses are approximate to put a cramp in excessive rollers’ fashion – it’s no longer unusual to peer luxury manufacturers’ operations take successful quickly after sizeable market pullbacks. Moreover, the financial boom is projected to slow next 12 months, and that tends to be a caution sign for normal overall performance at casinos, too. (Investors searching out a current example simply need to look at Macau, the Chinese playing hub that’s slumping amid that united states of America’s financial sluggishness.)

The analyst projection that matters: a 1% pullback in revenues for the subsequent year. That, as well as LVS’ ho-hum profits, don’t encourage confidence that Las Vegas Sands will lead a bull rise up in opposition to the bears.